Repligen Corp. (RGEN)
163.00
+2.33
(+1.45%)
USD |
NASDAQ |
Dec 10, 15:13
Repligen Market Cap: 9.175B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Enovis Corp. | 1.573B |
| Teleflex, Inc. | 5.672B |
| Globus Medical, Inc. | 11.84B |
| Perspective Therapeutics, Inc. | 192.16M |
| Xtant Medical Holdings, Inc. | 103.60M |
Market Cap Related Metrics
| PE Ratio | 6317.83 |
| PS Ratio | 12.99 |
| Price to Book Value | 4.405 |
| Price to Free Cash Flow | 88.87 |
| Price | 163.00 |
| Earnings Yield | 0.02% |
| Operating PE Ratio | 196.83 |
| Normalized PE Ratio | 271.49 |